FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1144474002: Margetuximab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4542083016 Margetuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542084010 Margetuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542083016 Margetuximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4542084010 Margetuximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Margetuximab (substance) Is a Human epidermal growth factor receptor 2 inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Margetuximab (substance) Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Margetuximab (substance) Is a Enzyme inhibitor protein true Inferred relationship Existential restriction modifier (core metadata concept)
Margetuximab (substance) Has disposition Human epidermal growth factor receptor 2 inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Margetuximab (substance) Is a Antineoplastic agent (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Margetuximab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Margetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Margetuximab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Margetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Margetuximab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Margetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Margetuximab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Margetuximab (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start